Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in soft tissue sarcoma.

E A Levine1

  • 1Department of Surgery, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA. elevine@wfubmc.edu

Seminars in Surgical Oncology
|July 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.

The British journal of surgery·2014
Same author

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer.

Minerva chirurgica·2012
Same author

Importance of gender in diffuse malignant peritoneal mesothelioma.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.

Journal of surgical oncology·2010
Same author

Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion.

Cancer treatment and research·2007
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Accurately predicting soft tissue sarcoma (STS) prognosis remains challenging. This review explores current and emerging prognostic factors beyond the American Joint Commission on Cancer (AJCC) staging system to improve patient risk stratification and treatment selection.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Accurate prognosis for soft tissue sarcoma (STS) is difficult.
  • Current staging relies on tumor size, grade, location, and metastasis (AJCC system).

Purpose of the Study:

  • To review prognostic factors for STS patients.
  • To discuss factors within and beyond the current AJCC staging system.
  • To explore newer markers for improved risk stratification and adjuvant therapy selection.

Main Methods:

  • Literature review focusing on prognostic factors in STS.
  • Discussion of established clinical criteria.
  • Exploration of novel and emerging prognostic markers.

Main Results:

  • The American Joint Commission on Cancer (AJCC) staging system uses traditional factors.

Related Experiment Videos

  • Several additional clinical markers offer prognostic value.
  • Emerging markers show potential for enhanced prognostication.

    • Conclusions:

    • Prognostic factors beyond the AJCC system are crucial for STS patient management.
    • Newer markers may refine risk assessment and guide adjuvant therapy decisions.
    • Continued research into prognostic factors will improve STS patient outcomes.